Blue Jet Healthcare IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 840.27 Cr. The company is based in Mumbai and caters to Pharmaceutical sector. ICICI Securities , J.P. Morgan India , Kotak Mahindra Capital Company are the merchant bankers of Blue Jet Healthcare IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 2nd September 2022.
Blue Jet Healthcare IPO posted revenues of ₹ 738.40 crores and PAT of ₹ 176.48 crores in FY24 on annualised basis.Financial results of Blue Jet Healthcare IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Financials | Jun-23 | FY23 | FY22 | FY21 | |
---|---|---|---|---|---|
Balance Sheet
|
|||||
Assets | 903.80 | 862.06 | 713.37 | 536.27 | |
Net Worth | 725.68 | 681.48 | 521.54 | 339.81 | |
Total Debt | [●] | [●] | [●] | 51.55 | |
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
179.54
718.16 |
720.98 | 683.46 | 498.93 | |
EBITDA
EBITDA on annualised basis |
206.05
824.20 |
219.08 | 38.31 | 58.95 | |
PAT
PAT on annualised basis |
44.12
176.48 |
160.02 | 181.59 | 135.78 |
Blue Jet Healthcare IPO PAT Margin is 24.57 % , ROCE (Return on Capital Employed) is 49.70 % as per latest financial. The below table shows Blue Jet Healthcare IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
Particulars | Jun-23 | FY23 | FY22 | FY21 |
---|---|---|---|---|
EBITDA Margin (%) | 114.77 | 30.39 | 5.61 | 11.82 |
PAT Margin (%) | 24.57 | 22.19 | 26.57 | 27.21 |
EPS (₹) | 2.54 | 9.23 | 10.47 | 7.98 |
ROE (%) | 6.08 | 23.48 | 34.82 | 39.96 |
ROCE (%) | 49.70 | 31.91 | 6.67 | 7.97 |
ROA (%) | 4.88 | 18.56 | 25.46 | 25.32 |
Debt to Equity | [●] | [●] | [●] | 0.15 |
The market Capitalisation of Blue Jet Healthcare IPO is ₹ 6001.90 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Blue Jet Healthcare IPO prospectus highlights an Return on Equity (ROE) of 6.08 % , Return on Assets (ROA) of 4.88 %, and an EBITDA Margin of 114.77 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Blue Jet Healthcare IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Blue Jet Healthcare IPO is ₹ 6001.90 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Blue Jet Healthcare IPO has a Price-to-Earnings (PE) ratio of 26.07 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Blue Jet Healthcare IPO reported revenue of ₹ 738.40 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Blue Jet Healthcare IPO provide insights into sales growth, market demand, and business scalability.
Blue Jet Healthcare recorded an EBITDA of ₹ 824.20 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Blue Jet Healthcare Profit After Tax (PAT) is ₹ 176.48 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Blue Jet Healthcare operates in Pharmaceutical and Pharma Intermediates API And Artificial Sweeteners. The Issue is listed on BSE,NSE in Nov, 2023. Blue Jet Healthcare IPO size was 840.27 with Issue price of 346.00 .
Merchant Banker(s) of Blue Jet Healthcare IPO: ICICI Securities Limited , J.P. Morgan India Private Limited , Kotak Mahindra Capital Company Limited
Blue Jet Healthcare IPO subscription was 7.95 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Blue Jet Healthcare IPO listed at a listing price of 395.85 against the offer price of 346.00.
The current market price of Blue Jet Healthcare is 869.65.
Why Us?